Cancidas

Active Ingredient(s): Caspofungin
FDA Approved: * January 26, 2001
Pharm Company: * MERCK RES
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cancidas Overview

Caspofungin (INN)[1][3] (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard.[4] It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-...

Read more Cancidas Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Caspofungin

Recent Cancidas Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Caspofungin
  • Injection: 50mg, 50mg/vial, 70mg, 70mg/vial
  • Powder: 50mg/vial, 70mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cancidas: (2 results)

Sorted by National Drug Code
  • 0006-3822 Cancidas 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.
  • 0006-3823 Cancidas 7 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.

Other drugs which contain Caspofungin or a similar ingredient: (1 result)